[1]
2024. Neutralizing Interleukin-13 with Tralokinumab Reduces Abundance of S. aureus in Adolescents with Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine. 8, 1 (Jan. 2024), s324. DOI:https://doi.org/10.25251/skin.8.supp.324.